-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – TAS-117
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry TAS-117 Drug Details TAS-117 is under development for the treatment of solid tumors including...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ta-1505
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry Ta-1505 Drug Details Ta-1505 is under development for the treatment of Alzheimer's disease (AD)....
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – TAS-3681
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry TAS-3681 Drug Details TAS-3681 is under development for the treatment of metastatic castration-resistant prostate...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – pimitespib
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry pimitespib Drug Details Pimitespib (Jeselhy) belongs to a class of antineoplastic drugs. It is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – recifercept
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry recifercept Drug Details Recifercept (TA-46) is under development for the treatment of achondroplasia. It...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – pegcetacoplan
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry pegcetacoplan Drug Details Pegcetacoplan (Empaveli, Aspaveli) is a synthetic peptide acts as a complement...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – obicetrapib
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry obicetrapib Drug Details Obicetrapib (AMG-899, DEZ-001, TA-8995) is under development for Alzheimer's disease, atherosclerosis,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – gatipotuzumab
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry gatipotuzumab Drug Details Gatipotuzumab (PankoMab GEX) is under development for the treatment of head...
-
Sector Analysis
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...